Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Teva
Fuji
Deloitte
US Department of Justice
Covington
Baxter
Daiichi Sankyo
Merck
Boehringer Ingelheim

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,231,573

« Back to Dashboard

Which drugs does patent 8,231,573 protect, and when does it expire?


Patent 8,231,573 protects AUVI-Q and EVZIO and is included in three NDAs.

This patent has one hundred patent family members in fourteen countries.

Summary for Patent: 8,231,573

Title:Medicament delivery device having an electronic circuit system
Abstract: Medicament delivery devices are described herein. In some embodiments, an apparatus includes a medical injector and an electronic circuit system. The medical injector includes a housing, a medicament container, and a medicament delivery member. The housing defines a first region and a second region. The first region includes the medicament container and is physically isolated from the second region. The electronic circuit system is configured to be disposed within the second region defined by the housing. The electronic circuit system is configured to output an electronic output associated with a use of the medical injector.
Inventor(s): Edwards; Eric S. (Midlothian, VA), Edwards; Evan T. (Fredericksburg, VA), Licata; Mark J. (Doswell, VA), Meyers; Paul F. (Fishers, IN), Weinzierl; David A. (Andover, MN)
Assignee: Intelliject, Inc. (Richmond, VA)
Application Number:12/119,016
Patent Claim Types:
see list of patent claims
Dosage form; Delivery; Device; Composition;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Kaleo IncAUVI-QepinephrineINJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS201739-002Aug 10, 2012BXRXYesYes► Subscribe► Subscribe► SubscribeY
Kaleo IncAUVI-QepinephrineINJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS201739-001Aug 10, 2012BXRXYesNo► Subscribe► Subscribe► SubscribeY
Kaleo IncEVZIOnaloxone hydrochlorideSOLUTION;INTRAMUSCULAR, SUBCUTANEOUS205787-001Apr 3, 2014DISCNYesNo► Subscribe► Subscribe► SubscribeY
Kaleo IncEVZIOnaloxone hydrochlorideSOLUTION;INTRAMUSCULAR, SUBCUTANEOUS209862-001Oct 19, 2016RXYesYes► Subscribe► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 8,231,573

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,425,462Devices, systems, and methods for medicament delivery► Subscribe
8,361,026Apparatus and methods for self-administration of vaccines and other medicaments► Subscribe
7,918,823Devices, systems and methods for medicament delivery► Subscribe
8,608,698Devices, systems and methods for medicament delivery► Subscribe
9,278,182Devices, systems and methods for medicament delivery► Subscribe
9,327,077Medical injector with compliance tracking and monitoring► Subscribe
8,226,610Medical injector with compliance tracking and monitoring► Subscribe
9,278,177Medical injector with compliance tracking and monitoring► Subscribe
9,259,539Devices, systems and methods for medicament delivery► Subscribe
8,123,719Devices, systems and methods for medicament delivery► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 8,231,573

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Poland2285360► Subscribe
New Zealand589864► Subscribe
New Zealand570731► Subscribe
New Zealand560516► Subscribe
New Zealand555256► Subscribe
Mexico2008012446► Subscribe
Mexico2007009152► Subscribe
Mexico2007005946► Subscribe
Mexico337305► Subscribe
Mexico2010012334► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Fish and Richardson
Moodys
Boehringer Ingelheim
McKinsey
Federal Trade Commission
McKesson
Daiichi Sankyo
Dow
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot